Tuesday, December 2, 2025

funding application

 audio and conversation file with AD and non-AD progression? LLM 

https://cdmrp.health.mil/pubs/press/2025/25azrppreann

Transforming Research AwardThe PI must be an independent investigator at any career level.
CIT Partnership Option: an eligible PI, as above, and either
  • Career Initiation: an investigator three or more years from their terminal degree but no more than seven years into an independent position
    OR
  • Career Transition: an investigator transitioning from another field to the AD/ADRD/TBI/military health fields and has only nominal, if any, publications in the AD-related field.
  • Supports high-impact research that addressed the priority area of "Reduce risk and prevent AD/ADRD."
  • Projects must be responsive to a FY25 AZRP TrRA focus area:
    • Risk factor knowledge
    • Risk reduction solutions
  • Clinical trials are not supported, but studies with prospective human subjects' enrollment may be allowed.
    • Applications proposing clinical studies will require community collaboration.
  • Studies leveraging existing cohorts or data sets are encouraged.
  • Animal studies that are fully justified for relevance to human health are allowed.
    • Community collaboration is not required for projects that focus primarily on animal studies but is encouraged.
  • The CIT Option is available.
  • Submission of a preproposal is required; application submission is by invitation only.
  • Maximum period of performance is 4 years
Single PI:
  • Maximum funding of $1.0M for total costs.
CIT Partnership Option:
  • Maximum funding of $1.0M for total costs.

No comments:

Post a Comment